GS443902 (GS-441524 triphosphate), the triphosphate metabolite (active) of Remdesivir (GS-5734; Veklury) which is an FDA approved drug for treating COVID-19, is a novel highly potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 1.1 μM, 5 μM for RSV RdRp and HCV RdRp, respectively. It is the active triphosphate metabolite of Remdesivir.

纯度：≥98%

CAS：1355149-45-9